What is Verrix?
Verrix is a San Clemente, California-based innovator in the medical device sector, dedicated to safeguarding patients against healthcare-associated infections. The company's core technology, originating from NASA's Jet Propulsion Laboratory, leverages sophisticated optical physics, chemistry spectroscopy, and molecular biology. Through scientific acumen and collaborations with healthcare professionals, Verrix is pioneering transformative solutions for sterility assurance, environmental monitoring, and infection control.
How much funding has Verrix raised?
Verrix has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Verrix
PPP
Public-Private Partnership
What's next for Verrix?
The substantial late-stage funding context suggests Verrix is poised for significant scaling and market penetration. This strategic capital infusion is likely to accelerate the commercialization of its foundational sterility assurance technology, potentially expanding its reach in infection control and environmental monitoring solutions. The company's focus on advanced, NASA-derived technology positions it for substantial growth and market leadership in the critical healthcare safety segment.
See full Verrix company page
